NCLEX Review Guide: Poliomyelitis in Pediatric Patients

Poliomyelitis Fundamentals

• Poliomyelitis is an acute viral infection caused by the poliovirus that primarily affects the central nervous system and motor neurons. The virus has three serotypes (1, 2, 3) and spreads through the fecal-oral route and respiratory droplets.
• The disease progression includes an incubation period of 7-14 days, followed by potential paralytic complications affecting the spinal cord's anterior horn cells. Most infections (90-95%) are asymptomatic or cause mild flu-like symptoms.

Disease Stages and Symptoms

• Nonparalytic poliomyelitis presents with fever, headache, vomiting, stiff neck, and muscle pain lasting 2-10 days. This form accounts for the majority of symptomatic cases and has complete recovery potential.
• Paralytic poliomyelitis manifests with asymmetric flaccid paralysis, absence of deep tendon reflexes, and muscle atrophy. The paralysis typically affects lower extremities first and can progress to respiratory muscles requiring mechanical ventilation.

Acute Care Management

1. Respiratory Assessment: Monitor for signs of respiratory compromise including decreased oxygen saturation, use of accessory muscles, and changes in respiratory rate or pattern
2. Isolation Precautions: Implement contact and droplet precautions for hospitalized patients, especially during the acute phase when viral shedding is highest
3. Comfort Measures: Provide pain management through positioning, warm compresses, and analgesics as ordered; avoid aspirin due to Reye's syndrome risk
4. Mobility Support: Collaborate with physical therapy for range of motion exercises and assistive devices to prevent contractures and maintain function

Immunization Strategies

• Inactivated Poliovirus Vaccine (IPV) is the only polio vaccine used in the United States since 2000, given as a series of four doses at 2, 4, 6-18 months, and 4-6 years of age. IPV provides excellent immunity without risk of vaccine-associated paralytic poliomyelitis.
• Oral Poliovirus Vaccine (OPV) contains live attenuated virus and is still used in some countries for eradication efforts, but carries a small risk of vaccine-associated paralytic poliomyelitis in immunocompromised individuals.

• ☐ Can identify the causative agent of poliomyelitis
• ☐ Understands transmission methods and prevention
• ☐ Recognizes signs of paralytic vs nonparalytic polio
• ☐ Knows priority nursing interventions for respiratory monitoring
• ☐ Can differentiate between IPV and OPV vaccines
• ☐ Understands isolation precautions needed
• ☐ Recognizes that treatment is supportive, not curative